URG11 Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2018 Jun 30

PMID 29955600

Citations 9

Authors

Bin Pan

Yunlin Ye

Haiping Liu

Jianli Zhen

Hongmei Zhou

Yutong Li

Lijun Qu

Youke Wu

Chuanrong Zeng

Weifeng Zhong

Affiliations

Soon will be listed here.

Abstract

Upregulated gene 11 (URG11), a new gene upregulated by hepatitis B virus X protein, is involved in the development and progression of several tumors, including liver, stomach, lung, and colon cancers. However, the role of URG11 in prostate cancer remains yet to be elucidated. By determined expression in human prostate cancer tissues, URG11 was found significantly upregulated and positively correlated with the severity of prostate cancer, compared with that in benign prostatic hyperplasia tissues. Further, the mRNA and protein levels of URG11 were significantly upregulated in human prostate cancer cell lines (DU145, PC3, and LNCaP), compared with human prostate epithelial cell line (RWPE-1). Moreover, by the application of siRNA against URG11, the proliferation, migration, and invasion of prostate cancer cells were markedly inhibited. Genetic knockdown of URG11 also induced cell cycle arrest at G1/S phase, induced apoptosis, and decreased the expression level of -catenin in prostate cancer cells. Overexpression of URG11 promoted the expression of -catenin, the growth, the migration, and invasion ability of prostate cancer cells. Taken together, this study reveals that URG11 is critical for the proliferation, migration, and invasion in prostate cancer cells, providing the evidence of URG11 to be a novel potential therapeutic target of prostate cancer.

Citing Articles

Expression Analysis of Early Metastatic Seeding of Colorectal Cancer.

Sawada A, Ohira M, Hatanaka K, Matsui H, Ichikawa N, Yoshida T Ann Surg Oncol. 2023; 31(3):2101-2113.

PMID: 38063988 DOI: 10.1245/s10434-023-14714-7.

IGHG1 promotes malignant progression in breast cancer cells through the regulation of AKT and VEGF signaling.

Zhang Y, Fang X, Sun Y Biomol Biomed. 2023; 23(4):616-623.

PMID: 36883223 PMC: 10351095. DOI: 10.17305/bb.2022.8508.

VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Huo Q, Li Z, Chen S, Wang J, Li J, Xie N Cancer Cell Int. 2021; 21(1):272.

PMID: 34020650 PMC: 8140436. DOI: 10.1186/s12935-021-01955-3.

Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells and by blocking the activation of the FAK/AKT/β‑catenin signaling pathway.

Xing P, Wang Y, Zhang L, Ma C, Lu J Int J Mol Med. 2021; 47(6).

PMID: 33846784 PMC: 8041483. DOI: 10.3892/ijmm.2021.4926.

Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.

Soltysova A, Sedlackova T, Dvorska D, Jasek K, Chokhachi Baradaran P, Kajabova V Int J Mol Sci. 2020; 21(24).

PMID: 33348918 PMC: 7767066. DOI: 10.3390/ijms21249651.

References

Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y . Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res. 2004; 10(18 Pt 1):6239-47. DOI: 10.1158/1078-0432.CCR-04-0242. View

Seo W, Park S, Gwak J, Ju B, Chung J, Kang P . Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP. Biochem Biophys Res Commun. 2017; 486(4):1034-1039. DOI: 10.1016/j.bbrc.2017.03.158. View

Fan R, Li X, Du W, Zou X, Du R, Zhao L . Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma. Int J Cancer. 2010; 128(12):2980-93. DOI: 10.1002/ijc.25624. View

Fodde R, Brabletz T . Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007; 19(2):150-8. DOI: 10.1016/j.ceb.2007.02.007. View

Akiyama T . Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 2000; 11(4):273-82. DOI: 10.1016/s1359-6101(00)00011-3. View

Yardy G, Brewster S . Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis. 2005; 8(2):119-26. DOI: 10.1038/sj.pcan.4500794. View

Schneider J, Logan S . Revisiting the role of Wnt/β-catenin signaling in prostate cancer. Mol Cell Endocrinol. 2017; 462(Pt A):3-8. PMC: 5550366. DOI: 10.1016/j.mce.2017.02.008. View

Lian Z, Liu J, Li L, Li X, Clayton M, Wu M . Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology. 2006; 43(3):415-24. DOI: 10.1002/hep.21053. View

Oleary J, Hamilton J, Deane C, Valeyev N, Sandell L, Downing A . Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand Factor type C module) from collagen IIA. J Biol Chem. 2004; 279(51):53857-66. DOI: 10.1074/jbc.M409225200. View

10.

Nhieu J, Renard C, Wei Y, Cherqui D, Zafrani E, Buendia M . Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol. 1999; 155(3):703-10. PMC: 1866892. DOI: 10.1016/s0002-9440(10)65168-1. View

11.

Du R, Xia L, Sun S, Lian Z, Zou X, Gao J . URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway. J Cell Mol Med. 2009; 14(3):621-35. PMC: 3823461. DOI: 10.1111/j.1582-4934.2008.00622.x. View

12.

Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi H, Garin-Chesa P . Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem. 2000; 276(10):7408-14. DOI: 10.1074/jbc.M009604200. View

13.

Gronberg H . Prostate cancer epidemiology. Lancet. 2003; 361(9360):859-64. DOI: 10.1016/S0140-6736(03)12713-4. View

14.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

15.

Sagredo A, Sagredo E, Cappelli C, Baez P, Andaur R, Blanco C . TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells. Mol Oncol. 2017; 12(2):151-165. PMC: 5792731. DOI: 10.1002/1878-0261.12100. View

16.

Peng W, Zhang J, Liu J . URG11 predicts poor prognosis of pancreatic cancer by enhancing epithelial-mesenchymal transition-driven invasion. Med Oncol. 2014; 31(7):64. DOI: 10.1007/s12032-014-0064-y. View

17.

Foley R, Hollywood D, Lawler M . Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease. Endocr Relat Cancer. 2004; 11(3):477-88. DOI: 10.1677/erc.1.00699. View

18.

Lian Z, Liu J, Li L, Li X, Satiroglu Tufan N, Clayton M . Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia. 2003; 5(3):229-44. PMC: 1502406. DOI: 10.1016/S1476-5586(03)80055-6. View

19.

Glinsky G, Glinskii A, Stephenson A, Hoffman R, Gerald W . Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest. 2004; 113(6):913-23. PMC: 362118. DOI: 10.1172/JCI20032. View

20.

Wang L, Liu W, Tang H, Xie X, Zou C, Wang Y . DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma. Cancer Med. 2017; 6(5):982-993. PMC: 5430105. DOI: 10.1002/cam4.1009. View